Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more
Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labor and Welfare (MHLW)... Read more
Singapore: Taiwanese company ScinoPharm and US-based Foresee Pharmaceuticals have signed an investment agreement to form a joint venture.... Read more
Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen Biotech and its affiliates... Read more
Singapore: Australia-based Bone Medical, a biopharmaceutical company focused on the development of new medicines for musculoskeletal diseases,... Read more
Singapore: Orexo entered into an agreement with AstraZeneca regarding preclinical program OX-CLI for a potential novel treatment of respiratory... Read more
Singapore: The US FDA has approved Exjade (deferasirox) for the treatment of chronic iron overload in patients 10 years of age and older... Read more
Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-ever antimicrobial... Read more
Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WMI), a close affiliate... Read more
Singapore: European Commission has approved Novartis' Bexsero (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) for use in individuals... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
